mq719
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 4, 2023 (NCT05859074)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
- Basal Cell Carcinoma · Phase 1
- Carcinoma · Phase 1
- Carcinoma, Merkel Cell · Phase 1
- Carcinoma, Squamous Cell · Phase 1
- Hemangiosarcoma · Phase 1
- Melanoma · Phase 1
- Neoplasms · Phase 1
- Neoplasms, Adnexal and Skin Appendage · Phase 1
- Paget Disease, Extramammary · Phase 1
- Sarcoma, Kaposi · Phase 1
- Skin Neoplasms · Phase 1
- Squamous Cell Carcinoma of Head and Neck · Phase 1
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05859074 | Phase 1 | May 4, 2023 | Memorial Sloan-Kettering Cancer Center |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Memorial Sloan-Kettering Cancer Center | Academic/Hospital | 1 | 1 | 1 | 2023 |
1 organizations
Page 1 / 1